Mesothelioma Death from 9/11 Signals Start of Things to Come
Malignant mesothelioma has become the latest deadly cancer linked directly to the rescue, recovery and cleanup efforts following the 9/11 terrorist attack on New York City in 2001. The long-running threat has come to fruition. Eighteen years after Manhattan was engulfed in the asbestos-laced, toxic cloud of dust — caused primarily by the World Trade Center destruction — the first death from pleural mesothelioma attributed to 9/11 has been recorded. Nick Ursta, 52, from the southwestern part of Pennsylvania, died after a year-long battle with the rare cancer. Ursta, a construction worker and fireman by trade, was part of the White Oak EMS team that arrived in New York City the day after the attack to assist in recovery efforts. Margaret Ursta, his wife who also assisted at ground zero, told the Pittsburgh-Post Gazette that oncologists treating him at the University of Pittsburgh Medical Center attributed his death to the intense asbestos exposure during 9/11 cleanup and recovery efforts. “I’m not surprised at all,” oncologist Dr. Craig Stevens, Beaumont Cancer Center in Royal Oak, Michigan, told The Mesothelioma Center at Asbestos.com. “I’m sure there will be more. It was a known risk as soon as the buildings fell.” Click Image to Open A Look into the Future Ursta’s death may signal the start of things to come. Mesothelioma is caused primarily by the inhalation or ingestion of microscopic asbestos fibers, which wer...
In this study, we show that LOC389641 is involved in PTC, which suggests that it may be a target for TC therapies. PMID: 32940082 [PubMed - in process]
Conclusion: STAT6 may act as a prognostic biomarker and provide useful information for immunotherapy in thyroid carcinoma. PMID: 32940081 [PubMed - in process]
Conclusion: The results suggest that the regulation of miR-505/HNRNPM may be a novel strategy to improve the targeted therapy of HCC. PMID: 32940078 [PubMed - in process]
Authors: Moll SA, Wiertz IA, Vorselaars AD, Zanen P, Ruven HJ, van Moorsel CH, Grutters JC Abstract Aim: Cancer antigen 15-3 (CA 15-3) is a baseline biomarker in idiopathic pulmonary fibrosis (IPF), but its value during follow-up is unknown. Materials and methods: Associations between serum CA 15-3 and pulmonary function tests during 1-year follow-up were evaluated by a mixed model in 132 IPF treated with pirfenidone or nintedanib. Results: Increased baseline (median: 56 kU/l) and follow-up CA 15-3 levels were inversely associated with forced vital capacity and diffusing capacity of the lung for carbon monoxid...
Biomarkers for immune checkpoint inhibitors in non-small-cell lung cancer. Biomark Med. 2020 Jul;14(11):929-932 Authors: Fuschillo S, Battiloro C, Rocco D, D Gravara L, Motta A, Maniscalco M PMID: 32940076 [PubMed - in process]
Conclusion: Metabolite biomarker candidates for PC are useful for detecting high-risk IPMN, which can progress to PC. PMID: 32940075 [PubMed - in process]
Conclusion: This study indicated that approximately a third of the CRC patients are diagnosed with EMAST, hereupon EMAST as a prognostic and predictive biomarker should be more studied clinically. PMID: 32940074 [PubMed - in process]
This article aims to review current advances in revealing relationship between tumors and abnormal N-glycosylation and discuss leading-edge applications of N-glycosylation in developing novel tumor biomarkers. PMID: 32940073 [PubMed - in process]
CONCLUSIONS: Despite the relatively small sample size of the South Australian cohort, clinical and serological characteristics correspond closely with international descriptions. PMID: 32940213 [PubMed - as supplied by publisher]
Positive histopathologic assessment in salivary glands shows little impact on clinical features of established primary Sjögren's syndrome in a Korean population. Clin Exp Rheumatol. 2020 Sep 08; Authors: Park Y, Lee J, Koh JH, Choe JY, Sung YK, Lee SS, Shim SC, Kim JM, Kwon SR, Park SH, Kwok SK Abstract OBJECTIVES: The presence and severity of focal lymphocytic sialadenitis in minor salivary glands is a pathognomonic feature in primary Sjögren's syndrome (pSS). However, it has not been determined whether performing minor salivary gland biopsy (MSGB) in a setting of serologically and clinicall...
More News: Asbestosis | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | Cardiovascular & Thoracic Surgery | Chemistry | Environmental Health | Genetics | Hospitals | Kidney Cancer | Leukemia | Lymphoma | Melanoma | Mesothelioma | Nonmelanoma Skin Cancer | Occupational Health | Prostate Cancer | Skin | Skin Cancer | Study | Thyroid | Thyroid Cancer | Toxicology | Urology & Nephrology